These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32559398)

  • 21. Factors affecting the interindividual variability of warfarin dose requirement in adult Korean patients.
    Cho HJ; Sohn KH; Park HM; Lee KH; Choi B; Kim S; Kim JS; On YK; Chun MR; Kim HJ; Kim JW; Lee SY
    Pharmacogenomics; 2007 Apr; 8(4):329-37. PubMed ID: 17391071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of CYP2C9, CYP4F2 and VKORC1 genetic polymorphisms on pharmacokinetics and pharmacodynamics of mean daily maintenance dose of warfarin in Chinese patients.
    Zhuang W; Wen W; Xuan B; Chen Y; Cao Y; Sun Z; Ma J
    Blood Coagul Fibrinolysis; 2015 Mar; 26(2):167-74. PubMed ID: 25304014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new algorithm to predict warfarin dose from polymorphisms of CYP4F2 , CYP2C9 and VKORC1 and clinical variables: derivation in Han Chinese patients with non valvular atrial fibrillation.
    Wei M; Ye F; Xie D; Zhu Y; Zhu J; Tao Y; Yu F
    Thromb Haemost; 2012 Jun; 107(6):1083-91. PubMed ID: 22534826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.
    Issac MS; El-Nahid MS; Wissa MY
    Mol Diagn Ther; 2014 Feb; 18(1):73-83. PubMed ID: 24092646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of genetic factors (VKORC1, CYP2C9, CYP4F2 and EPHX1) on the anticoagulation response to fluindione.
    Lacut K; Ayme-Dietrich E; Gourhant L; Poulhazan E; Andro M; Becquemont L; Mottier D; Le Gal G; Verstuyft C
    Br J Clin Pharmacol; 2012 Mar; 73(3):428-36. PubMed ID: 21883387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pharmacogenetics-based warfarin maintenance dosing algorithm from Northern Chinese patients.
    Chen J; Shao L; Gong L; Luo F; Wang J; Shi Y; Tan Y; Chen Q; Zhang Y; Hui R; Wang Y
    PLoS One; 2014; 9(8):e105250. PubMed ID: 25126975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of VKORC1 and CYP2C9 gene polymorphisms in Indian population and its effect on warfarin response.
    Shalia KK; Doshi SM; Parikh S; Pawar PP; Divekar SS; Varma SP; Mehta R; Doctor T; Shah VK; Saranath D
    J Assoc Physicians India; 2012 Dec; 60():34-8. PubMed ID: 23781667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of warfarin dose-associated genotypes on the risk of hemorrhagic complications in Chinese patients on warfarin.
    Ma C; Zhang Y; Xu Q; Yang J; Zhang Y; Gao L; Xu B; Wang H; Li Y; Lu C; Yin T
    Int J Hematol; 2012 Dec; 96(6):719-28. PubMed ID: 23104259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of CYP2C9, VKORC1, and CYP4F2 polymorphisms on the pharmacodynamic parameters of warfarin: a cross-sectional study.
    Sridharan K; Al Banna R; Malalla Z; Husain A; Sater M; Jassim G; Otoom S
    Pharmacol Rep; 2021 Oct; 73(5):1405-1417. PubMed ID: 33811620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese.
    Zeng WT; Xu Q; Li CH; Chen WY; Sun XT; Wang X; Yang YY; Shi H; Yang ZS
    Eur J Clin Pharmacol; 2016 Nov; 72(11):1327-1334. PubMed ID: 27488389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients.
    Wattanachai N; Kaewmoongkun S; Pussadhamma B; Makarawate P; Wongvipaporn C; Kiatchoosakun S; Vannaprasaht S; Tassaneeyakul W
    Eur J Clin Pharmacol; 2017 Aug; 73(8):973-980. PubMed ID: 28550460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Warfarin Dose Model for the Prediction of Stable Maintenance Dose in Indian Patients.
    Gaikwad T; Ghosh K; Avery P; Kamali F; Shetty S
    Clin Appl Thromb Hemost; 2018 Mar; 24(2):353-359. PubMed ID: 28049362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis.
    Takeuchi M; Kobayashi T; Brandão LR; Ito S
    Syst Rev; 2016 Jun; 5(1):105. PubMed ID: 27334984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects.
    Nakamura K; Obayashi K; Araki T; Aomori T; Fujita Y; Okada Y; Kurabayashi M; Hasegawa A; Ohmori S; Nakamura T; Yamamoto K
    J Clin Pharm Ther; 2012 Aug; 37(4):481-5. PubMed ID: 22172097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of NR3C1 and VDR polymorphisms on stable warfarin dose in patients with mechanical cardiac valves.
    Lee KE; Chung JE; Yi B; Cho YJ; Kim HJ; Lee GY; Kim JH; Chang BC; Gwak HS
    Int J Cardiol; 2017 Jun; 236():393-397. PubMed ID: 28262345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Responsiveness to low-dose warfarin associated with genetic variants of VKORC1, CYP2C9, CYP2C19, and CYP4F2 in an Indonesian population.
    Rusdiana T; Araki T; Nakamura T; Subarnas A; Yamamoto K
    Eur J Clin Pharmacol; 2013 Mar; 69(3):395-405. PubMed ID: 22855348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics of Warfarin in a Diverse Patient Population.
    Mak M; Lam C; Pineda SJ; Lou M; Xu LY; Meeks C; Lin C; Stone R; Rodgers K; Mitani G
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):521-533. PubMed ID: 31064211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population.
    Veenstra DL; You JH; Rieder MJ; Farin FM; Wilkerson HW; Blough DK; Cheng G; Rettie AE
    Pharmacogenet Genomics; 2005 Oct; 15(10):687-91. PubMed ID: 16141794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To establish a model for the prediction of initial standard and maintenance doses of warfarin for the Han Chinese population based on gene polymorphism: a multicenter study.
    Xia X; Huang N; Li B; Li Y; Zou L; Yuan D; Huang B; Bei Y; Liu Y; Fu J; Wu T; Chen W; Jiang S; Lv M; Zhang J
    Eur J Clin Pharmacol; 2022 Jan; 78(1):43-51. PubMed ID: 34453556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impact of five genetic polymorphisms on inter-individual variation in warfarin maintenance dose].
    Huang SW; Xiang DK; Wu HL; Chen BL; An BQ; Li GF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):661-5. PubMed ID: 22161100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.